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Deletion of Fibroblast Growth Factor Receptor 2 from the
Peri-Wolffian Duct Stroma Leads to Ureteric Induction
Abnormalities and Vesicoureteral Reflux
Kenneth A. Walker1., Sunder Sims-Lucas1., Valeria E. Di Giovanni1, Caitlin Schaefer1,
Whitney M. Sunseri1, Tatiana Novitskaya2, Mark P. de Caestecker2, Feng Chen3, Carlton M. Bates4*
1 Rangos Research Center, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States of America, 2 Department of Medicine, Division of
Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America, 3 Renal Division, Department of Internal Medicine, Washington
University School of Medicine, St. Louis, Missouri, United States of America, 4 Division of Nephrology, Department of Pediatrics, University of Pittsburgh School of
Medicine, Pittsburgh, Pennsylvania, United States of America

Abstract
Purpose: Pax3cre-mediated deletion of fibroblast growth factor receptor 2 (Fgfr2) broadly in renal and urinary tract
mesenchyme led to ureteric bud (UB) induction defects and vesicoureteral reflux (VUR), although the mechanisms were
unclear. Here, we investigated whether Fgfr2 acts specifically in peri-Wolffian duct stroma (ST) to regulate UB induction and
development of VUR and the mechanisms of Fgfr2 activity.
Methods: We conditionally deleted Fgfr2 in ST (Fgfr2ST2/2) using Tbx18cre mice. To look for ureteric bud induction defects in
young embryos, we assessed length and apoptosis of common nephric ducts (CNDs). We performed 3D reconstructions and
histological analyses of urinary tracts of embryos and postnatal mice and cystograms in postnatal mice to test for VUR. We
performed in situ hybridization and real-time PCR in young embryos to determine mechanisms underlying UB induction
defects.
Results: We confirmed that Fgfr2 is expressed in ST and that Fgfr2 was efficiently deleted in this tissue in Fgfr2ST2/2 mice at
embryonic day (E) 10.5. E11.5 Fgfr2ST2/2 mice had randomized UB induction sites with approximately 1/3 arising too high
and 1/3 too low from the Wolffian duct; however, apoptosis was unaltered in E12.5 mutant CNDs. While ureters were
histologically normal, E15.5 Fgfr2ST2/2 mice exhibit improper ureteral insertion sites into the bladder, consistent with the
ureteric induction defects. While ureter and bladder histology appeared normal, postnatal day (P) 1 mutants had high rates
of VUR versus controls (75% versus 3%, p = 0.001) and occasionally other defects including renal hypoplasia and duplex
systems. P1 mutant mice also had improper ureteral bladder insertion sites and shortened intravesicular tunnel lengths that
correlated with VUR. E10.5 Fgfr2ST2/2 mice had decreases in Bmp4 mRNA in stromal tissues, suggesting a mechanism
underlying the ureteric induction and VUR phenotypes.
Conclusion: Mutations in FGFR2 could possibly cause VUR in humans.
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abnormal positioning of the ureteral insertion site into the bladder
and increased likelihood of vesicoureteral reflux in humans and
animal models [3,4].
VUR may be present in up to 2% of children and is associated
with the development of reflux nephropathy, a leading cause of
pediatric chronic kidney disease [5]. In addition to abnormal
position of ureteral insertion into the bladder, VUR has been
associated with a number of other defects including shortened
intravesicular ureteral tunnel lengths [5,6,7] and bladder and
ureteral muscle defects [8]. Despite some insights into pathophysiology, the genetics of VUR remain unclear. VUR follows a

Introduction
Murine metanephric kidney development starts at E10.5 when
an outgrowth from the Wolffian duct, the ureteric bud, is induced
by the adjacent metanephric mesenchyme (MM) [1]. The UB
induction site is constrained to its proper position by tailbud
mesenchyme derived stroma (ST) lying between the Wolffian duct
and MM [2]. Perturbed growth factor signaling within the ST
such as haploinsufficiency of bone morphogenetic protein 4
(Bmp4) causes a shift in the UB induction site leading to urinary
tract anomalies including ectopic ureters and renal hypoplasia [2].
In addition, aberrant ureteric induction sites are associated with
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dominant inheritance pattern, however no single gene defect has
been shown to cause the majority of VUR cases [5].
Fibroblast growth factor receptors 1 and 2 are critical for
different stages and lineages of kidney development [9–17]. While
conditional deletion of Fgfr1 with the transgenic Pax3cre line in the
peri-Wolffian duct stroma and MM resulted in no kidney defects,
Pax3cre-mediated deletion of Fgfr2 led to UB induction abnormalities and high rates of VUR [9,10,11]. Despite these data, it is
unclear whether deletion of Fgfrs in the ST or the MM drives the
abnormalities and what downstream targets mediate the actions of
Fgfr2.
To determine whether loss of Fgfr2 in the ST alters ureteric
induction leading to VUR, we utilized a Tbx18cre mouse line [18]
to delete Fgfr2 expression in peri-Wolffian duct stroma but not in
MM. E11.5 Fgfr2ST2/2 mice exhibit aberrant ureteric induction
with approximately 1/3 arising too high and 1/3 too low from the
Wolffian duct. 3D imaging of E15.5 mutants revealed abnormal
ureteral insertion sites into the bladder, consistent with the ureteric
induction defects. P1 mutants had high rates of VUR associated
with improper ureteral insertion sites into the bladder and
shortened intravesicular tunnel lengths. Rarely Fgfr2ST2/2 mice
had other anomalies such as renal hypoplasia or duplex systems.
Loss of Fgfr2 in ST led to a decrease in Bmp4 expression at E10.5
that is likely the reason for the ureteric induction defects.

collagenase into a cellular suspension in preparation for flow
cytometry. Tbx18cre+ve cells were FACsorted from other cells via
the presence of RFP. Following flow cytometry, cells from each
genotype were pooled for subsequent Real-time PCR analysis.

Real-time PCR
For quantitative analysis mRNA expression, six E10.5
Fgfr2ST2/2 and control urogenital ridges, or pooled cells as
mentioned previously, were collected and RNA extracted using a
Mini-prep kit (Qiagen, Valencia, CA). To analyze gene expression, TaqManH Gene Expression assays for Fgfr2, Ret and Bmp4
and Gapdh (NM_008084.2; endogenous control) were utilized
(Invitrogen, Carlsbad, CA). Quantitative real-time PCR was
performed as described [21] on an Applied Biosystems ABI
7900 HT (Foster City, CA).

Common nephric duct length, proliferation and
apoptosis
To assess common nephric duct (CND) length E11.5 urogenital
ridges from Fgfr2ST2/2 and cre negative littermate control
embryos were dissected into ice cold methanol, washed in PBS,
blocked and stained whole mount with a pan-cytokeratin antibody
(1:10; Sigma Aldrich) followed by goat anti-mouse Alex Fluor 594
(1:500; Sigma Aldrich) to visualize the ureteric bud and Wolffian
duct. Stained urogenital ridges were mounted and imaged using a
confocal microscope. CND length from the caudal end of the
nephric duct at the cloaca to the cranial edge of the ureteral bud
stalk origin was measured using Imaris software (Bitplane, Zurich,
Switzerland).
To investigate proliferation in the CND, E12.5 Fgfr2ST2/2 and
littermate control embryos were fixed in 4%PFA/PBS, embedded
in paraffin and serially sectioned at 10 mm through the urogenital
sinus and CND. Sections were then labeled with antibodies against
phospho-histone H3 (pH3: 1:200; Sigma Aldrich) and E-Cadherin
(Ecad: 1:250; Sigma Aldrich) to visualize proliferating cells and the
CND respectively. We detected Phospho-histone H3 with goat
anti-rabbit Alex Fluor 594 and E-Cadherin with donkey anti-rat
Alex Fluor 488 (1:500; Molecular Probes). A minimum of three
sections through the CND, at 20 mm intervals were assessed for
each embryo of each genotype.
To examine apoptosis of the CND, methanol fixed E12.5
Fgfr2ST2/2 and littermate control urogential blocks (including
mesonephros, metanephros, ureter, gonads and cloaca) were
examined using whole mount immunofluorescence with antibodies
against pan-cytokeratin (1:10; Sigma Aldrich) to visualize CNDs
and activated caspase-3 (1:250, Invitrogen) to detect apoptosis, as
described previously [22]. We detected cytokeratin with goat antimouse Alex Fluor 488 and activated caspase 3 with donkey antirabbit Alex Fluor 594 (1:500; Molecular Probes).

Materials and Methods
Mice
Tbx18creTg/+ mice that drive cre expression in the peri-Wolffian
duct stroma [18] were bred with Fgfr2Lox/Lox mice, a gift from Dr.
David Onritz [19], to produce Tbx18Tg/+Fgfr2Lox/Lox mice with
deletion of Fgfr2 in the ST (Fgfr2ST2/2). To detect cre expression,
Tbx18creTg/+ and Fgfr2ST2/2 mice were bred with Cag:RFPTg/+
reporter mice (Cag-Tbx18creTg/+ and Cag-Fgfr2ST2/2) to generate
offspring in which red fluorescent protein (RFP) is expressed at the
site of cre recombinase [20]. For embryonic studies, timed
overnight matings were generated; when a vaginal plug was
identified, noon of that day was deemed E0.5. All experiments
were carried out with approval of the University of Pittsburgh
Institutional Animal Care and Use Committee.

Genotyping
DNA was extracted from tail clippings or embryonic tissues for
PCR genotyping, as described [9]. The following genotyping
primers were used to detect respective gene expression: Tbx18cre 59-CCATCCAACAGCACC TGGGCCAGCTCAACA-39 and
5-CCACCATCGGTGCGGGAGATGTCCTTCACT-39, Fgfr2
- 59-GTCAATTCTAAGCCACTGTCTGCC-39 (wildtype allele),
59-CTCCACTGATTACATCTAAAGAGC-39 (floxed allele),
CAG – 59-AAG GGA GCT GCA GTG GAG TA-39, 59-CCG
AAA ATC TGT GGG AAG TC-39 (wildtype allele), 59-GGC
ATT AAA GCA GCG TAT CC-39, 59-CTG TTC CTG TAC
GGC ATG G-39 (Cag allele).

Cystograms
To assess for VUR, euthanized cystograms were performed in
P1 Fgfr2ST2/2 and littermate control pups as described [22].
Briefly, mice were euthanized and abdominal walls were reflected
to expose the bladder. A 30-gauge needle was inserted into the
bladder and 1% methylene blue dye was gravity filled into the
bladder via a 50 ml syringe. Starting at a height of 0 cm, the
syringe was raised 30 cm at 5-second intervals to a final height of
150 cm, at which time the syringe was maintained for 15 seconds.
The presence of dye ascending from the bladder towards the
kidney was determined as VUR. All VUR was graded according
to international classifications [23]. At the completion of the assay,

Gene Expression Analysis
Whole-mount in situ hybridization (WISH) was performed on
E10.5 control and Fgfr2ST2/2 tissues as described [9]. Briefly,
digoxigenin UTP-labeled antisense RNA probes were generated
against Bmp4 (Gene Accession number: NM007554.2), Fgfr2
(NM201601.2) and Ret (NM001080780.1).

Fluorescence Activated Cell Sorting (FACS)
Six E10.5 Cag-Tbx18creTg/+ and Cag-Fgfr2ST2/2 urogenital
ridges were dissected and then manually disassociated with 0.3%
PLOS ONE | www.plosone.org
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all kidneys were photographed for assessment of kidney long axis
via Image J software (National Institute of Health).

Three-Dimensional (3D) Reconstructions
Whole E15.5 embryos and lower body P1 (post-cystogram)
tissues from control and Fgfr2ST2/2 mice were fixed in 4%
paraformaldehyde overnight at 4uC, dehydrated and paraffin
embedded. Tissues were serially sectioned at 10 mm through the
ureters and bladder, and stained with hematoxylin and eosin
(H&E). Bladders and ureteral insertion sites were reconstructed
into three-dimensional models as previously described [10].

Histology and Immunohistochemistry

Figure 1. Expression of the Tbx18cre in E10.5 mouse embryos
and urogenital tracts. A. E10.5 Cag-Tbx18creTg/+ mice demonstrate
cre expression noted by RFP staining (red) in numerous tissues
including fore- and hindlimbs, spine and urogenital ridges. B. Ventral
view of dissected urogenital ridges illustrates robust cre expression in
the peri-Wolffian duct stroma at E10.5 (highlighted between arrowheads). Scale bars = 100 mm. ***p,0.001 vs. control embryos.
doi:10.1371/journal.pone.0056062.g001

All tissues were fixed in 4% paraformaldehyde overnight at 4uC,
dehydrated and paraffin embedded. Tissues were sectioned at
either 6 or 10 mm and stained with H&E to evaluate tissue
morphology. For immunohistochemistry sections were dewaxed,
antigen retrieved using citrate buffer, permeabilized using 5%
tween in PBS, blocked with 1% donkey serum in PBS, and
incubated overnight with alpha smooth muscle actin (aSMA:
1:250; Sigma Aldrich) and E-cadherin (Ecad: 1:250; Sigma
Aldrich) at 4uC. Sections were then washed and incubated for
1 hour at room temperature with secondary antibodies (Rabbit
anti-Mouse 594: 1:500; Donkey anti-Rat 488: 1:500; Molecular
Probes) and DAPI (1:10,000) diluted in 1% donkey serum in PBS.
Sections were then washed, mounted and visualized.

observed in peri-wolffian duct stroma on the dorsal surface of the
urogenital tract at E10.5 (Figure 1B). To confirm deletion of Fgfr2
in peri-Wolffian duct stroma in Fgfr2ST2/2 mice, we performed
whole-mount in situ hybridization for Fgfr2 in E10.5 embryos. In
control embryos, a wide band of Fgfr2 mRNA expression was
visualized in both the Wolffian duct and peri-Wolffian duct stroma
(Figure 2A, 2C). In Fgfr2ST2/2 embryos, we observed linear Fgfr2
expression in the Wolffian duct epithelium, but absent expression
in the peri-Wolffian duct stroma (Figure 2B, 2D). We also
dissected, dissociated, and FACsorted E10.5 Cag-Tbx18creTg/+
(control) and Cag-Fgfr2ST2/2 urogenital ridge cells; after isolating
mRNA, we confirmed a nearly complete loss of Fgfr2 expression in
the Tbx18cre expressing urogenital ridge cells in Fgfr2ST2/2 mice
(5% Fgfr2 expression in Fgfr2ST2/2 mice relative to controls;
Figure 2E). Thus, these data confirm the Fgfr2ST2/2 mice as a
model of conditional deletion of Fgfr2 in the peri-Wolffian duct
stroma.

Statistics
One-way ANOVA followed by Bonferroni’s post-hoc analysis,
student’s T-tests and fisher’s exact test analyses were conducted
where appropriate, using GraphPad PrismTM 5 (GraphPad
Software Inc, 1992–2007).

Results
Tbx18cre and Fgfr2 expression in the peri-Wolffian duct
stroma
To confirm expression of the Tbx18cre during ureteric
induction deletion we crossed Tbx18cre mice with a CAG:RFP
reporter mouse line (Figure 1A). Robust cre expression was

Figure 2. Expression of Fgfr2 in E10.5 in control and Fgfr2ST2/2 embryos. A,C. Lower power (A) and higher power (C) images show that
control embryos have a wide band of Fgfr2 signal (between arrowheads) encompassing the Wolffian duct and surrounding stroma. B,D. Lower power
(B) and higher power (D) images show that Fgfr2ST2/2 embryos have a linear band of Fgfr2 expression in the Wolffian duct epithelium (arrows) and
not in the surrounding stroma. E. Quantitative real-time PCR of FAC-sorted E10.5 Cag-Tbx18creTg/+ (Control) and Cag-Fgfr2ST2/2 (Fgfr2St2/2) urogenital
ridges confirms a dramatic decrease in Fgfr2 mRNA expression in mutant Tbx18cre expressing cells. Scale bars = 100 mm. ***p,0.001 vs. control
embryos.
doi:10.1371/journal.pone.0056062.g002
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Figure 3. Common nephric duct (CND) lengths in E11.5 control and Fgfr2ST2/2 embryos. A–C. Whole mount cytokeratin immunostaining
reveals that compared with control common nephric duct lengths (A, line), mutants often have duct lengths that are longer (B, line) or shorter (C,
line). Arrows indicate the boundaries of the CND. Scale bar = 100 mm. D. Graph demonstrating that the majority of duct lengths in controls are within
1SD of the mean (between the lines), whereas the majority of the Fgfr2ST2/2 lengths are less than or greater than 1SD of the control mean. E. Graph
demonstrating that the majority of control CND lengths within the same embryo are within one control SD (line), whereas the majority of Fgfr2ST2/2
duct lengths within the same embryo differ by greater than one control SD. *p,0.05, **p,0.01 vs. control embryos.
doi:10.1371/journal.pone.0056062.g003

Similarly, phospho-histone H3 staining of cells in the CND of
control and Fgfr2ST2/2 embryos demonstrated a similar percentage of proliferating cells in both genotypes at E12.5 (Figure S2).
Together indicating that aberrant ureteric bud induction is not
associated with changes in CND apoptosis or proliferation (either
decreases or increases) at later stages Thus, deletion of Fgfr2 from
the peri-Wolffian duct stroma induces aberrant UB induction
relative to controls.

Aberrant ureteric bud induction following deletion of
Fgfr2 from ST
Previously, deletion of Fgf2 expression with a transgenic Pax3cre
line in the MM and peri-Wolffian duct stroma was associated with
aberrant UB induction [10]. To determine if deletion of Fgfr2 in
ST is sufficient to induce abnormal ureteric budding, we measured
the common nephric duct length in E11.5 urogenital ridges after
performing whole mount cytokeratin staining (Figure 3A–C).
Mean CND lengths were similar between controls and mutants
(Control: 170.75625.34 mm; Fgfr2ST2/2: 182.74653.92 mm;
p = 0.5, Figure 3D). However, it appeared that the mutants had
a tri-modal distribution of CND lengths as opposed to control
CND lengths that appeared to have a Gaussian distribution
(Figure 3D). In Fgfr2ST2/2 mice, 69% of the CND lengths were
.1 control SD away from the mean (both shorter and longer),
whereas only 20% of the control CND lengths were .1 control
SD from the mean (p = 0.01). Mutants also had a greater intraembryo variability in CND length between right and left sides than
controls; 75% (6/8) of Fgfr2ST2/2 mice had intra-embryonic CND
lengths that were .1 control SD different between the right and
left side, whereas only 29% (2/7) of controls had intra-embryonic
CND lengths that were .1 SD different between each side
(p = 0.04) (Figure 3E). Despite the differences in CND length at
E11.5, whole-mount activated caspases-3 staining illustrates
similar patterns of ventral apoptosis of the distal CND in both
control and Fgfr2ST2/2 urogenital ridges at E12.5 (Figure S1).

Fgfr2ST2/2 embryos have improper ureteral insertion in
bladders at E15.5
To determine whether the ureteric induction defects led to
abnormal ureteral insertion in the bladder during embryogenesis,
we performed H&E staining and 3D reconstructions of E15.5
control and Fgfr2ST2/2 lower urinary tracts. Histologically, the
E15.5 ureters and bladders appeared normal (Figure S3). After
performing 3D reconstructions (Figure 4), we determined the
position of the ureter insertions into the bladder in two ways: First,
we generated triangles connecting the two external ureteral
insertion sites and the bladder neck (external bladder trigone)
from which we could determine whether ureters were displaced.
Second, we noted the ureteral insertion site in relation to the plane
of the pubic symphysis, which we used as an anatomic reference
point.
In control embryos, ureteral insertion occurs just superior to the
pubic symphysis, with both ureters inserting into the bladder at a

Figure 4. Three-dimensional reconstructions of ureteral insertion sites into the bladders of E15.5 control and Fgfr2ST2/2 embryos. A
Ureter (blue) insertion sites (arrowheads) in control embryos occur just above the level of the pubic symphysis (white plane) in a symmetric pattern.
B–C. Fgfr2ST2/2 embryos have asymmetric ureteral insertion into the developing bladder, one with a low left insertion (B, *) and one with a high left
insertion (C, *). D–F. External trigone of the control (from A) shows a normal inverted isosceles triangle (D), whereas the mutants (from B & C) have
distorted external trigones with marked differences in angles at the insertion sites (E, F). G. Graph demonstrating the differences in external trigonal
angles are much greater in mutants than controls **p,0.01; (n) = 3 per genotype; Values are mean+SD. yellow = bladder surface; pink = bladder
lumen.
doi:10.1371/journal.pone.0056062.g004
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either genotype. Lastly, while Fgfr2ST2/2 mice occasionally had
other urinary tract anomalies including duplex collecting systems/
kidneys and renal hypoplasia (Figure S4) with an incidence higher
than in controls [Control: 0% (0/72) versus Fgfr2ST2/2: 16% (6/
31); p,0.001].

Refluxing P1 Fgfr2ST2/2 mice have improper ureteral
insertion and shortened intravesicular tunnel lengths
We then sought to determine whether there were defects in
either urinary tract morphology and/or in ureteral insertion that
could explain the high rates of VUR in Fgfr2ST2/2 mice. Thus we
performed histological assays and 3D reconstructions of the lower
urinary tracts of P1 mice after cystograms. Morphologically, P1
mutant bladders and ureters appeared normal by H&E staining
and by immunostaining with markers for muscle and urothelium
(Figure 6). However, as in E15.5 mutants, 3D reconstructions
revealed abnormal unilateral ureteral insertion sites into the
bladders of P1 Fgfr2ST2/2 mice with VUR (including high and low
insertions) but normal-appearing insertion sites in mutants without
VUR (Figure 7 and not shown). Quantitatively, P1 controls and
Fgfr2St2/2 mice without VUR had right and left external angles
that were generally within 10u whereas mutants with unilateral
reflux had average differences of approximately 35u (Figure 7E).
Furthermore, ureters from Fgfr2ST2/2 mice that refluxed had
significantly shortened intravesicular tunnel lengths compared
with both control and non-refluxing Fgfr2ST2/2 ureters (Control:
286.1647.92 mm; Fgfr2ST2/2 with no reflux: 302.18644.41 mm;
Fgfr2ST2/2 with reflux: 186.23639.76 mm; p,0.001) (Figure 7F).
Thus the presence of VUR correlated with displaced ureteral
insertion sites into the bladder and shorter intravesicular tunnel
lengths.

Figure 5. Representative cystograms in P1 Fgfr2ST2/2 and
control mice. A. Control ureters have no dye (between arrowheads)
indicating no VUR. B. Fgfr2ST2/2 mouse has dye in the right ureter up to
the renal pelvis (*) indicating grade II VUR. Bl indicates the bladder.
Scale bar = 500 mm.
doi:10.1371/journal.pone.0056062.g005

similar anatomical level (Figure 4A). Furthermore, the control
external trigones formed nearly perfect inverted isosceles triangles
with similar-appearing angles formed at the insertion sites
(Figure 4D). In contrast, Fgfr2ST2/2 embryos usually had one
displaced ureter including those with low bladder insertions
(Figure 4B) and others with high bladder insertions (Figure 4C)
relative to the pubic symphysis. The external trigones formed
triangles that were distorted from the shape of an isosceles triangle
with significant differences between angles formed at the insertion
sites (Figure 4E–F). Quantitatively, controls had right and left
external angles that were generally within 10u whereas mutants
had average differences of approximately 30u (Figure 4G). Thus,
E15.5 Fgfr2ST2/2 embryos had evidence of improper unilateral
ureteral insertion consistent with the ureteric induction defects
noted earlier.

Fgfr2 deletion results in decreased Bmp4 expression in
urogenital regions
Bmp4, which is secreted by the peri-Wolffian duct stroma, is
known to constrain the ureteric bud to its proper induction site
along the Wolffian duct [6]. Given that deletion of Fgfr2 in this
tissue leads to defects in ureteric induction, we examined
Fgfr2ST2/2 mutants at E10.5 for changes in Bmp4 and Ret
expression. Whole mount in situ hybridization at E10.5 illustrated
that Fgfr2ST2/2 embryos have significantly less Bmp4 mRNA
expression in the peri-Wolffian duct stroma relative to controls
(Figure 8). In contrast, ureteric bud and Wolffian duct expression
of Ret mRNA appeared similar between both genotypes.
Quantitative real-time PCR of dissected urogenital ridges
confirmed ,40% reductions in Bmp4 mRNA expression in
Fgfr2ST2/2 embryos relative to controls while Ret expression was
equivalent (Figure 8). Thus, the decrease in Bmp4 expression in
Fgfr2ST2/2 embryos correlates with the ureteric induction defects
that likely lead to VUR and other phenotypes observed in the
mutant mice [6,7].

Fgfr2ST2/2 mice have high incidence of VUR and
occasionally other urinary tract anomalies at birth
Given the evidence of ureteric induction defects and improper
ureteral insertion in the bladder in embryos, we assessed P1
Fgfr2ST2/2 mice for VUR with cystograms by gravity filling
bladders with methylene blue dye. As shown, P1 Fgfr2ST2/2 mice
(excluding those with duplex ureters) had high rates of vesicoureteral reflux relative to control littermates (Figure 5, Table 1). The
VUR in Fgfr2ST2/2 mice had no gender bias (Table 1). In
addition, mutants usually had unilateral VUR with only one
Fgfr2ST2/2 mouse exhibiting bilateral reflux (Table 1). The
mutants most frequently had grade II VUR followed by grade
III VUR while the few control mice with VUR had grade I reflux
(Tables 1 and 2). No VUR greater than grade III was observed in

Table 1. Incidence and severity of VUR at P1 in control and Fgfr2ST2/2 mice.

Genotype

Incidence of Reflux
Total

Male

Female

Unilateral Reflux Observed

Grade of Reflux

Unilateral

Grade I–II

Bilateral

Grade III–V

Control

3% 2/76

4% 2/45

0% 0/31

100% 2/2

N/A 0/0

100% 2/2

N/A

Fgfr2ST2/2

75%*** 23/31

72% 13/18

77% 10/13

96% 22/23

4% 1/23

78% 18/23

22% 5/23

***p,0.001 vs. control, analysis via a Fisher’s Exact Test.
doi:10.1371/journal.pone.0056062.t001
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Table 2. Grades of VUR at P1 in control and Fgfr2ST2/2 mice.

Genotype

Grade I

Grade II

Grade III

Total

Male

Female

Total

Male

Female

Total

Male

Female

Control

100% (2/2)

2

0

0

0

0

0

0

0

Fgfr2ST2/2

9% (2/23)*

1

1

69% (16/23)

9

7

22% (5/23)

3

2

*p,0.05 vs. control, analysis via a Fisher’s Exact Test.
doi:10.1371/journal.pone.0056062.t002

metanephric mesenchyme [9–17]. Using a Pax3cre transgenic
line, we determined that deletion of Fgfr2 in both the peri-Wolffian
duct stroma and the metanephric mesenchyme led to ureteric
induction defects and subsequent VUR and other anomalies such
as duplex systems and renal hypoplasia; however, it was unclear as
to the contribution of each of these tissues to those defects [9,10].
By utilizing the Tbx18cre mouse line that drives cre expression in the
peri-Wolffian duct stroma and not in the metanephric mesenchyme, we now conclude that Fgfr2 expression in the peri-Wolffian
duct stroma is most critical for regulating the ureteric bud
induction site and preventing VUR and other urinary tract
anomalies.
We did observe some differences between Fgfr2ST2/2 mice and
Pax3creTg/+Fgfr2Lox/Lox mice [10]. First, we detected higher rates of
VUR in Fgfr2ST2/2 mice compared to the Pax3cre mice; this
discrepancy could be due to more complete deletion of Fgfr2 in the
peri-Wolffian duct stroma with the Tbx18cre line versus the Pax3cre
line, as cre expression in the MM has been shown to be variable
with the Pax3cre line when bred with reporter mice (Drs. Valeria
Di Giovanni and Norman Rosenblum, unpublished observations).
In addition, we noted shortened intravesicular tunnel lengths and
both cranial and caudal displacement of ureteric bud induction
sites in Fgfr2ST2/2, whereas the Pax3cre mutant mice had normal
tunnel lengths and only cranially displaced ureteric buds. We
suspect that we had more power in the current study (larger
numbers of mutant mice and higher VUR rates) than the previous
study and were therefore able to detect these defects in the
Fgfr2ST2/2 mice.
The reason for the VUR in the Fgfr2ST2/2 mice appears to be
secondary to ureteric bud induction defects, leading to abnormal
ureteric induction sites and incompetent anti-reflux mechanisms,
as described by Drs. Mackie and Stephens in humans with VUR
[24,25]. The reflux observed does not appear to be related to a
persistence or premature loss of the CND, as apoptosis and
proliferation were unaltered in the mutant mice at E12.5.
Fgfr2ST2/2 mutants did have evidence of abnormal ureteral
insertion sites in the bladder by E15.5; moreover, abnormal
position of the ureteral insertion site correlated directly with the
presence of VUR in P1 mutants. The P1 mutant ureters with
VUR also had shortened intravesicular tunnel lengths, which is
known to further increase the risks of VUR in humans [5]. Most of
the P1 Fgfr2ST2/2 mice had unilateral VUR, which likely reflects
that many of the ureteric bud induction sites at E11.5 were at or
near the normal position. We did not detect any histological
defects in the ureters or bladders during development or in adult
mice to explain the VUR. Finally, we noted other urinary tract
anomalies in the mutants including duplex systems and renal
hypoplasia, which likely reflect the ureteric induction defects. The
high incidence of VUR and the presence of all the aforementioned
anatomical features in Fgfr2ST2/2 mice are very consistent with
the Mackie-Stephens hypothesis for the developmental origin of
VUR in our mice [24,25].

Discussion
Fibroblast growth factor receptors, their ligands and their
downstream signaling adapters have previously been shown to be
integral for the development of the metanephric kidney, often by
conditional deletion in the Wolffian duct/ureteric bud and/or

Figure 6. Bladder and ureter morphology in P1 Fgfr2ST2/2 and
control mice following cystograms. A–B. H&E staining shows
similar bladder histology between controls (A) and mutants (B). C–D.
Immunofluorescence (IF) also shows normal urothelium (green) and
alpha smooth muscle actin staining (red) in control (C) and Fgfr2ST2/2
mice (D). E–H. H&E staining and IF shows normal urothelium and
muscle layers in control ureters (E, G) and mutant ureters (F, H). Arrows
indicate muscle layer; Arrowheads indicate urothelium. Scale bar = A–D:
300 mm, E–H: 500 mm.
doi:10.1371/journal.pone.0056062.g006
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Figure 7. Three-dimensional reconstructions of ureteral insertion sites into the bladders of P1 control and Fgfr2ST2/2 embryos. A–B.
Control mouse without VUR (A) has ureters (blue) that insert into bladders (yellow) at the same level, whereas the Fgfr2St2/2 mouse with left sided
VUR (B) has a high and laterally displaced ureteral insertion site on that side (*). C–D. External trigone drawn from the control (from A) shows similar
right and left sided external angles whereas the mutant (from B) has a marked differences in the left and right external angles. E. Graph
demonstrating that the differences in external trigonal angles are much greater in mutants with VUR than controls or mutants without VUR. Values in
E–F are mean+SD; ***p,0.001 vs. control and vs. Fgfr2St2/2 mutants without VUR).
doi:10.1371/journal.pone.0056062.g007

An important finding of the current study is a likely molecular
mechanism responsible for the ureteric induction defects (and
associated CAKUTs and VUR) in Fgfr2ST2/2 mice. While we

previously found that reduction of Fgfr expression in kidney
mesenchyme led to increases in Ret expression in the ureteric bud
[16], we found no evidence of altered Ret expression in the UB or
Wolffian duct in Fgfr2ST2/2 embryos. Moreover, signaling
through Fgfrs has been shown to directly and indirectly regulate
expression of secreted growth factors, such as Bmp4 [16,26]. In the
current study, Fgfr2ST2/2 mice exhibit a ,40% reduction in Bmp4
mRNA expression prior at E10.5, at the onset of ureteric bud
induction. Interestingly, in situ hybridization indicated that the
entire field of Bmp4 expression seen in control embryos at this
stage was significantly reduced in Fgfr2ST2/2 mice. Furthermore,
it is possible that this wide area of decreased Bmp4 expression in
the peri-Wolffian duct stroma adjacent to the metanephric
mesenchyme may account for the variability in the site of ureteric
bud induction observed in Fgfr2ST2/2 mice. Moreover, Bmp4
heterozygous mice have a 40% reduction in Bmp4 mRNA levels
and have a high incidence of ureteric induction abnormalities
[6,7,27]. Reduced Bmp4 mRNA expression as seen in Bmp4
heterozygous mice or following disruption of upstream regulators
of Bmp4 is strongly associated with urinary tract anomalies such as
duplex systems and renal hypoplasia (they have not to our
knowledge been tested for VUR) [6,7,27,28]. Findings from our
study strongly suggest that Fgfr2 acts upstream of Bmp4 in the periWolffian duct stroma to maintain the proper ureteric induction
site.
In humans, dysregulation of both FGFRs and BMP4 have been
associated with a wide range of urinary tract abnormalities. Nonsyndromic kidney and urinary tract anomalies have been
associated with mutations in BMP4 in humans [29,30]. In addition
mutations in FGFRs lead to syndromes including Apert’s
syndrome, Antley-Bixler syndrome, Pfeiffer syndrome, and
Beare-Stevenson syndrome, which are sometimes associated with
urogenital anomalies such as hydroureter, solitary kidney, and
VUR [31]. Thus it is possible that unidentified mutations in FGFs
or FGFRs could affect BMP4 levels in humans leading to VUR
and other urinary tract anomalies; thus, FGF receptors and their

Figure 8. Expression of Bmp4 and Ret mRNA at E10.5 in control
and Fgfr2ST2/2 urogenital ridges. A–B. In situ hybridization for
Bmp4 shows apparent reduced expression in the peri-Wolffian duct
stroma in mutants (B, white arrowheads) versus controls (A, white
arrowheads). C–D. Graphs of real time PCR confirm that Fgfr2ST2/2
urogenital ridges have an ,40% reduction in Bmp4 mRNA (C), whereas
Ret mRNA levels are equivalent (D). Values are means normalized to
control expression levels; *p,0.05, **p,0.01 vs. control; n = 3
urogenital ridges per genotype per analysis. Dotted lines indicate the
dorsal aspect of the Wolffian duct in each image. Scale bar = 100 mm.
doi:10.1371/journal.pone.0056062.g008
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ligands are potential candidates for future genetic screening studies
in patients with VUR and other urinary tract defects.

embryos (B). C–D. H&E stains also shows similar ureter
morphology between controls (C) and mutants (D). Arrowheads
indicate mesenchymal (developing muscular) layer; Arrows
indicate urothelium. Scale bars = 300 mm.
(TIF)

Supporting Information
Figure S1 Representative images of apoptosis of the
CND at E12.5 in control and Fgfr2ST2/2 embryos. A–B.
Co-immunofluorescent labeling of pancytokeratin (red) and
activated caspase-3 (green) highlighted a similar pattern of
apoptosis (arrowhead) of the distal CND in both control and
Fgfr2ST2/2 embryos (the entire CND is between the arrows). Scale
bar = 100 mm.
(TIF)

Figure S4 P1 Fgfr2ST2/2 mice with duplex collecting

systems/kidneys and renal hypoplasia. A. Control kidney
shows normal gross morphology. B. Fgfr2ST2/2 mouse has a
duplex collecting system filled with dye (arrows) and a duplex
kidney (* = two kidney moieties). C. Fgfr2ST2/2 mouse has a
hypoplastic kidney. Scale bar = 500 mm.
(TIF)

Figure S2 Cell proliferation in the CND at E12.5 in
control and Fgfr2ST2/2. A–B. Co-immunofluorescent labeling
of phosphor-histone H3 (red; proliferating cells) and E-Cadherin
(green; urothelium) illustrates cell proliferation in the CND
(arrowhead) in both control and Fgfr2ST2/2 embryos. C.
Quantification of proliferation in the CND indicates no differences
between control and Fgfr2ST2/2 embryos at E12.5. Dotted line
indicates CND; Cl – Cloaca. Scale bar = 50 mm.
(TIF)
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